Skip to main content
Premium Trial:

Request an Annual Quote

NIDCD Issues RFA for Projects Studying Protein Interactions in Auditory, Vestibular Biology

NEW YORK, June 28 (GenomeWeb News) - The National Institute on Deafness and Other Communication Disorders has issued a request for applications on projects studying protein interactions involved in auditory and vestibular development.


According to NIDCD, the goal of the RFA is to "initiate comprehensive approaches using multiple molecular techniques to study regulatory and signaling proteins important in auditory and vestibular developmental biology. Information gained from these approaches will provide insight to specific protein regulatory networks important to auditory and vestibular function," the institute said.


NIDCD noted that application for studies using high-throughput proteomics approaches are not being considered. Studies eligible for funding include, but are not limited to, ones focused on the use of auditory and vestibular proteins in bacterial or yeast two-hybrid systems to detect putative protein interactions and candidates; mutational analysis of proteins in auditory and vestibular biology; and the use of purified reconstitution systems to assess protein function involved in auditory and vestibular biology, said NIDCD.


NIDCD said that it expects to commit roughly $1.5 million in fiscal 2005 to fund 3 or 4 new grants in response to this RFA.  Additional details about the RFA can be found here.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.